Montelukast Sodium Structural Formula (Montelukast Sodium 10mg Tab For Glenmark 1)
Montelukast Sodium
Product Images NDC 33261-969
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 33261-969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Montelukast Sodium 10mg Tab For Glenmark 2)
This is a graph showing the mean percent change from baseline for a treatment period of 15 weeks, followed by a washout period. The x-axis shows the weeks in treatment and the y-axis shows the percent change from baseline. There are two treatments shown, placebo (represented by a dotted line) and Montelukast Sodium (represented by a solid line). The graph spans from week 0 to week 15. The graph is useful in evaluating the effect of the two treatments over a 15-week period.*
Glenmark Logo (Montelukast Sodium 10mg Tab For Glenmark 3)
The text is not-available.*
Glenmark Logo (Montelukast Sodium 10mg Tab For Glenmark 4)
Image Label (Montelukast Sodium 10mg Tab For Glenmark 5)
This is a description for a medication called Montelukast, manufactured by Aidarex Pharmaceuticals LLC and Glenmark Generics LTD. The medication has active ingredients of 10 mg Montelukast Sodium and is used to treat certain types of asthma and to relieve the symptoms of seasonal allergies. The medication should not be taken without a prescription and must be stored at controlled room temperature. The package contains 90 tablets, and the dosage is usually one tablet taken orally twice daily.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
